Back to Authors

Dhankikar, Swati

Mayo Clinic

Mayo Clinic

Citations 4

The influence of antidepressants and actigraphy-derived sleep characteristics on pediatric multiple sleep latency testing
Dhankikar, Swati, Kotagal, Suresh , Kolla, Bhanu Prakash , Mansukhani, Meghna P.

Journal of Clinical Sleep Medicine | May 20, 2021 | Volume: 17 | Issue: 11 | Pages: 2179-2185

10.5664/jcsm.9338 Get It

Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency
Kondori, Marjan Jahani, Silber, Michael H. , Samman, Hala, Dhankikar, Swati, Kolla, Bhanu Prakash , Jahani Kondori, Marjan, Samman, Hala, Mansukhani, Meghna P.

Journal of Clinical Sleep Medicine | August 11, 2020 | Volume: 16 | Issue: 11 | Pages: 1921-1927

10.5664/jcsm.8738 Get It

0738 Advance Taper of Antidepressants Prior to Multiple Sleep Latency Testing Increases the Number of Sleep-Onset Rapid Eye Movement Periods and Reduces Mean Sleep Latency
Kondori, M Jahani, Silber, Michael H. , Samman, Hala, Dhankikar, Swati, Kolla, Bhanu Prakash , Kondori, Marjan Jahani, Mansukhani, Meghna P.

Sleep | May 27, 2020 | Volume: 43 | Issue: Supplement_1 | Pages: A281-A281

10.1093/sleep/zsaa056.734 Get It

Abstract Introduction Patients presenting with excessive sleepiness are frequently on antidepressant medication(s). While practice parameters recommend discontinuation of antidepressants prior to multiple sleep latency testing (MSLT), data examining the impact of tapering these medications on MSLT results are limited. Methods Adult patients who underwent MSLT at Mayo Clinic Rochester, Minnesota, between 2014-2018 were included. Clinical and demographic characteristics, medications, including use of rapid eye movement suppressing antidepressants (REMS-AD) at assessment and during testing, actigraphy and polysomnography data were manually abstracted. The difference in number of sleep-onset rapid eye movement periods (SOREMS), proportion with ≥2 SOREMS and mean sleep latency (MSL) in patients who were on REMS-AD and discontinued prior to testing versus those who remained on REMS-AD were examined. At our center, all antidepressants are discontinued 2 weeks prior to MSLT wherever feasible; fluoxetine is stopped 4 weeks prior. Regression analyses accounting for demographic, clinical and other medication-related confounders were performed. Results A total of 502 patients (age=38.18±15.90 years; 67% female) underwent MSLT; 178 (35%) were on REMS-AD at the time of assessment. REMS-AD were discontinued prior to testing in 121/178 (70%) patients. Patients tapered off REMS-AD were more likely to have ≥2 SOREMS (OR-12.20; 95%CI=1.60-92.94) compared to patients who remained on REMS-AD at the time of the MSLT. They also had shorter MSL (8.77±0.46 vs 10.21±0.28; p>0.009) and higher odds of having ≥2 SOREMS (OR=2.22; 95%CI=1.23-3.98) compared to patients not on REMS-AD at initial assessment. These differences persisted after regression analyses accounting for confounders. Conclusion Patients who taper off REMS-AD prior to MSLT are more likely to demonstrate ≥2SOREMs and have a shorter MSL. Pending further prospective investigations, clinicians should preferably withdraw REMs-AD before an MSLT. If this is not done, the test interpretation should include a statement regarding the potential effect of the drugs on the results. Support None
0764 The Diagnostic Conundrum Posed By Antidepressant Medications While Conducting The Pediatric Mslt
Dhankikar, Swati, Kotagal, Suresh , Julie, Baughn, Mansukhani, Meghna P.

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A307-A307

10.1093/sleep/zsz067.762 Get It